205 related articles for article (PubMed ID: 16360884)
21. Class II transactivator-mediated regulation of major histocompatibility complex class II antigen expression is important for hematopoietic progenitor cell suppression by chemokines and iron-binding proteins.
Broxmeyer HE; Cooper S; Hangoc G; Chang CH
Exp Hematol; 2006 Aug; 34(8):1078-84. PubMed ID: 16863914
[TBL] [Abstract][Full Text] [Related]
22. [Major histocompatibility complex class II transactivator (CIITA) hammer- head ribozyme transfer inhibits major histocompatibility complex class II (MHC-II) expression in Jukart cells].
Guo R; Zou P; Song YP; Ma J; Lu HZ; Cao YL; Tong YJ
Zhonghua Er Ke Za Zhi; 2003 Dec; 41(12):925-8. PubMed ID: 14723817
[TBL] [Abstract][Full Text] [Related]
23. Autoimmunity and inflammation are independent of class II transactivator type PIV-dependent class II major histocompatibility complex expression in peripheral tissues during collagen-induced arthritis.
Waldburger JM; Palmer G; Seemayer C; Lamacchia C; Finckh A; Christofilopoulos P; Baeten D; Reith W; Gabay C
Arthritis Rheum; 2011 Nov; 63(11):3354-63. PubMed ID: 21739421
[TBL] [Abstract][Full Text] [Related]
24. Interferon-gamma induces major histocompatibility class II transactivator (CIITA), which mediates collagen repression and major histocompatibility class II activation by human aortic smooth muscle cells.
Butticè G; Miller J; Wang L; Smith BD
Circ Res; 2006 Mar; 98(4):472-9. PubMed ID: 16439692
[TBL] [Abstract][Full Text] [Related]
25. MHC class II transactivator (CIITA) expression is upregulated in multiple myeloma cells by IFN-gamma.
Zhao M; Flynt FL; Hong M; Chen H; Gilbert CA; Briley NT; Bolick SC; Wright KL; Piskurich JF
Mol Immunol; 2007 Apr; 44(11):2923-32. PubMed ID: 17300840
[TBL] [Abstract][Full Text] [Related]
26. Absence of MHC class II antigen expression in trophoblast cells results from a lack of class II transactivator (CIITA) gene expression.
Murphy SP; Tomasi TB
Mol Reprod Dev; 1998 Sep; 51(1):1-12. PubMed ID: 9712312
[TBL] [Abstract][Full Text] [Related]
27. Two distinct gamma interferon-inducible promoters of the major histocompatibility complex class II transactivator gene are differentially regulated by STAT1, interferon regulatory factor 1, and transforming growth factor beta.
Piskurich JF; Linhoff MW; Wang Y; Ting JP
Mol Cell Biol; 1999 Jan; 19(1):431-40. PubMed ID: 9858567
[TBL] [Abstract][Full Text] [Related]
28. γ-Interferon-regulated chaperone governs human lymphocyte antigen class II expression.
Kämper N; Franken S; Temme S; Koch S; Bieber T; Koch N
FASEB J; 2012 Jan; 26(1):104-16. PubMed ID: 21940994
[TBL] [Abstract][Full Text] [Related]
29. Nitric oxide and KLF4 protein epigenetically modify class II transactivator to repress major histocompatibility complex II expression during Mycobacterium bovis bacillus Calmette-Guerin infection.
Ghorpade DS; Holla S; Sinha AY; Alagesan SK; Balaji KN
J Biol Chem; 2013 Jul; 288(28):20592-606. PubMed ID: 23733190
[TBL] [Abstract][Full Text] [Related]
30. [The expression and significance of major histocompatibility complex II transactivator gene in five human malignant hematological cell lines].
You Y; Zou P; Guo R
Zhonghua Nei Ke Za Zhi; 2004 Apr; 43(4):288-91. PubMed ID: 15130416
[TBL] [Abstract][Full Text] [Related]
31. Regulation of MHC class II expression by interferon-gamma mediated by the transactivator gene CIITA.
Steimle V; Siegrist CA; Mottet A; Lisowska-Grospierre B; Mach B
Science; 1994 Jul; 265(5168):106-9. PubMed ID: 8016643
[TBL] [Abstract][Full Text] [Related]
32. Nitric oxide inhibits INFgamma-induced increases in CIITA mRNA abundance and activation of CIITA dependent genes--class II MHC, Ii and H-2M. Class II TransActivator.
Kielar ML; Sicher SC; Penfield JG; Jeyarajah DR; Lu CY
Inflammation; 2000 Oct; 24(5):431-45. PubMed ID: 10921507
[TBL] [Abstract][Full Text] [Related]
33. Effect of transforming growth factor-beta1 on microglial MHC-class II expression.
Pazmany T; Kosa JP; Tomasi TB; Mechtler L; Turoczi A; Lehotzky A
J Neuroimmunol; 2000 Mar; 103(2):122-30. PubMed ID: 10696907
[TBL] [Abstract][Full Text] [Related]
34. Polycomb recruitment at the Class II transactivator gene.
Boyd NH; Morgan JE; Greer SF
Mol Immunol; 2015 Oct; 67(2 Pt B):482-91. PubMed ID: 26283540
[TBL] [Abstract][Full Text] [Related]
35. Peroxisome proliferator-activated receptor gamma interacts with CIITA x RFX5 complex to repress type I collagen gene expression.
Xu Y; Farmer SR; Smith BD
J Biol Chem; 2007 Sep; 282(36):26046-56. PubMed ID: 17611194
[TBL] [Abstract][Full Text] [Related]
36. Reduced IL-4-, lipopolysaccharide-, and IFN-gamma-induced MHC class II expression in mice lacking class II transactivator due to targeted deletion of the GTP-binding domain.
Itoh-Lindstrom Y; Piskurich JF; Felix NJ; Wang Y; Brickey WJ; Platt JL; Koller BH; Ting JP
J Immunol; 1999 Sep; 163(5):2425-31. PubMed ID: 10452977
[TBL] [Abstract][Full Text] [Related]
37. Regulation of MHC class II expression and antigen processing in murine and human mesenchymal stromal cells by IFN-gamma, TGF-beta, and cell density.
Romieu-Mourez R; François M; Boivin MN; Stagg J; Galipeau J
J Immunol; 2007 Aug; 179(3):1549-58. PubMed ID: 17641021
[TBL] [Abstract][Full Text] [Related]
38. Different levels of control prevent interferon-gamma-inducible HLA-class II expression in human neuroblastoma cells.
Croce M; De Ambrosis A; Corrias MV; Pistoia V; Occhino M; Meazza R; Giron-Michel J; Azzarone B; Accolla RS; Ferrini S
Oncogene; 2003 Oct; 22(49):7848-57. PubMed ID: 14586411
[TBL] [Abstract][Full Text] [Related]
39. STAT1-independent down-regulation of interferon-gamma-induced class II transactivator and HLA-DR expression by transforming growth factor beta-1 in human glomerular endothelial cells.
Yang WS; Han NJ; Kim CS; Ahn H; Lee SK; Lee KU; Park SK
Nephron Exp Nephrol; 2005; 100(3):e124-31. PubMed ID: 15824515
[TBL] [Abstract][Full Text] [Related]
40. Identification of distinct regions of 5' flanking DNA that mediate constitutive, IFN-gamma, STAT1, and TGF-beta-regulated expression of the class II transactivator gene.
Piskurich JF; Wang Y; Linhoff MW; White LC; Ting JP
J Immunol; 1998 Jan; 160(1):233-40. PubMed ID: 9551976
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
